Skip to main content
NCBI home page
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
. 1993 Jan;18(1):4–16.

Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

B Dubrovsky 1
PMCID: PMC1188470  PMID: 8461280

Abstract

Cushing's disorder and depression present overlapping although not identical psychological symptomatology. In turn, a subset of patients with affective disorders present with hypercortisolemia and disturbances, specifically disinhibition, of the hypothalamic hypophysio adrenal axis (HHAA). Memory disturbances, in particular, biasing toward negative contents, overlapping sleep abnormalities (marked reduction of stages 3 and 4) increased fatigue and loss of energy, attentional deficits and irritability, are just part of the common symptomatology presented by patients with both Cushing's disorder and depression. All of these behavioral manifestations are known to be affected by adrenal steroid hormones. There is consensus that hippocampal structures are a main target for adrenal steroid hormones; hence, these neural regions are some of the most likely mediators of the effects of corticoadrenal steroids on behavior. This paper proposes that an imbalance of adrenal steroids and their metabolites may play a fundamental role in the psychophysiopathology of Cushing's and depressive disorders. The imbalance of these hormones, especially at limbic sites, could distort mood and memory content affecting cognition based on recollection and present experiences. Reestablishing an adrenal balance could therefore be considered as a therapeutic aid in a subset of depressive disorders.

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ankier S. I., Leonard B. E. Biological aspects of depression: a review of the etiology and mechanisms of action and clinical assessment of antidepressants. Int Rev Neurobiol. 1986;28:183–239. doi: 10.1016/s0074-7742(08)60109-9. [DOI] [PubMed] [Google Scholar]
  2. Arana G. W., Mossman D. The dexamethasone suppression test and depression. Approaches to the use of a laboratory test in psychiatry. Endocrinol Metab Clin North Am. 1988 Mar;17(1):21–39. [PubMed] [Google Scholar]
  3. Arbas E. A., Meinertzhagen I. A., Shaw S. R. Evolution in nervous systems. Annu Rev Neurosci. 1991;14:9–38. doi: 10.1146/annurev.ne.14.030191.000301. [DOI] [PubMed] [Google Scholar]
  4. Avanzino G. L., Celasco G., Cogo C. E., Ermirio R., Ruggeri P. Actions of microelectrophoretically applied glucocorticoid hormones on reticular formation neurones in the rat. Neurosci Lett. 1983 Jul 15;38(1):45–49. doi: 10.1016/0304-3940(83)90108-8. [DOI] [PubMed] [Google Scholar]
  5. Bliss T. V., Goddard G. V., Riives M. Reduction of long-term potentiation in the dentate gyrus of the rat following selective depletion of monoamines. J Physiol. 1983 Jan;334:475–491. doi: 10.1113/jphysiol.1983.sp014507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Born J., DeKloet E. R., Wenz H., Kern W., Fehm H. L. Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol. 1991 Feb;260(2 Pt 1):E183–E188. doi: 10.1152/ajpendo.1991.260.2.E183. [DOI] [PubMed] [Google Scholar]
  7. Brady L. S., Whitfield H. J., Jr, Fox R. J., Gold P. W., Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J Clin Invest. 1991 Mar;87(3):831–837. doi: 10.1172/JCI115086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CLEGHORN R. A. Adrenal cortical insufficiency: psychological and neurological observations. Can Med Assoc J. 1951 Nov;65(5):449–454. [PMC free article] [PubMed] [Google Scholar]
  9. Cain D. P. Long-term potentiation and kindling: how similar are the mechanisms? Trends Neurosci. 1989 Jan;12(1):6–10. doi: 10.1016/0166-2236(89)90146-x. [DOI] [PubMed] [Google Scholar]
  10. Calogero A. E., Gallucci W. T., Gold P. W., Chrousos G. P. Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. J Clin Invest. 1988 Sep;82(3):767–774. doi: 10.1172/JCI113677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Carroll, Curtis G. C., Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry. 1976 Sep;33(9):1039–1044. doi: 10.1001/archpsyc.1976.01770090029002. [DOI] [PubMed] [Google Scholar]
  12. Celotti F., Melcangi R. C., Negri-Cesi P., Ballabio M., Martini L. Differential distribution of the 5-alpha-reductase in the central nervous system of the rat and the mouse: are the white matter structures of the brain target tissue for testosterone action? J Steroid Biochem. 1987 Jan;26(1):125–129. doi: 10.1016/0022-4731(87)90040-9. [DOI] [PubMed] [Google Scholar]
  13. Chen Y. Z., Hua S. Y., Wang C. A., Wu L. G., Gu Q., Xing B. R. An electrophysiological study on the membrane receptor-mediated action of glucocorticoids in mammalian neurons. Neuroendocrinology. 1991;53 (Suppl 1):25–30. doi: 10.1159/000125791. [DOI] [PubMed] [Google Scholar]
  14. Cohen S. I. Cushing's syndrome: a psychiatric study of 29 patients. Br J Psychiatry. 1980 Feb;136:120–124. doi: 10.1192/bjp.136.2.120. [DOI] [PubMed] [Google Scholar]
  15. Conn P. M., Conti M., Harwood J. P., Dufau M. L., Catt K. J. Internalisation of gonadotrophin--receptor complex in ovarian luteal cells. Nature. 1978 Aug 10;274(5671):598–600. doi: 10.1038/274598a0. [DOI] [PubMed] [Google Scholar]
  16. Coryell W., Gaffney G., Burkhardt P. E. The dexamethasone suppression test and familial subtypes of depression--a naturalistic replication. Biol Psychiatry. 1982 Jan;17(1):33–40. [PubMed] [Google Scholar]
  17. Coryell W., Tsuang D. Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8-year follow-up. Am J Psychiatry. 1992 Aug;149(8):1033–1039. doi: 10.1176/ajp.149.8.1033. [DOI] [PubMed] [Google Scholar]
  18. Csaba G. Phylogeny and ontogeny of hormone receptors: the selection theory of receptor formation and hormonal imprinting. Biol Rev Camb Philos Soc. 1980 Feb;55(1):47–63. doi: 10.1111/j.1469-185x.1980.tb00687.x. [DOI] [PubMed] [Google Scholar]
  19. Davies A. O., Lefkowitz R. J. Regulation of beta-adrenergic receptors by steroid hormones. Annu Rev Physiol. 1984;46:119–130. doi: 10.1146/annurev.ph.46.030184.001003. [DOI] [PubMed] [Google Scholar]
  20. Davies C. H., Starkey S. J., Pozza M. F., Collingridge G. L. GABA autoreceptors regulate the induction of LTP. Nature. 1991 Feb 14;349(6310):609–611. doi: 10.1038/349609a0. [DOI] [PubMed] [Google Scholar]
  21. Davies S. N., Lester R. A., Reymann K. G., Collingridge G. L. Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation. Nature. 1989 Apr 6;338(6215):500–503. doi: 10.1038/338500a0. [DOI] [PubMed] [Google Scholar]
  22. Deisz R. A., Fortin G., Zieglgänsberger W. Voltage dependence of excitatory postsynaptic potentials of rat neocortical neurons. J Neurophysiol. 1991 Feb;65(2):371–382. doi: 10.1152/jn.1991.65.2.371. [DOI] [PubMed] [Google Scholar]
  23. Delbende C., Delarue C., Lefebvre H., Bunel D. T., Szafarczyk A., Mocaër E., Kamoun A., Jégou S., Vaudry H. Glucocorticoids, transmitters and stress. Br J Psychiatry Suppl. 1992 Feb;(15):24–35. [PubMed] [Google Scholar]
  24. Diamond D. M., Bennett M. C., Engstrom D. A., Fleshner M., Rose G. M. Adrenalectomy reduces the threshold for hippocampal primed burst potentiation in the anesthetized rat. Brain Res. 1989 Jul 17;492(1-2):356–360. doi: 10.1016/0006-8993(89)90919-0. [DOI] [PubMed] [Google Scholar]
  25. Dubrovsky B. O., Liquornik M. S., Noble P., Gijsbers K. Effects of 5 alpha-dihydrocorticosterone on evoked responses and long-term potentiation. Brain Res Bull. 1987 Dec;19(6):635–638. doi: 10.1016/0361-9230(87)90049-9. [DOI] [PubMed] [Google Scholar]
  26. Dubrovsky B. Adrenal steroids and the physiopathology of a subset of depressive disorders. Med Hypotheses. 1991 Nov;36(3):300–305. doi: 10.1016/0306-9877(91)90153-p. [DOI] [PubMed] [Google Scholar]
  27. Dubrovsky B., Filipini D., Gijsbers K., Birmingham M. K. Early and late effects of steroid hormones on the central nervous system. Ciba Found Symp. 1990;153:240–260. doi: 10.1002/9780470513989.ch14. [DOI] [PubMed] [Google Scholar]
  28. Dubrovsky B., Williams D., Kraulis I. Effects of deoxycorticosterone and its ring A-reduced derivatives on the nervous system. Exp Neurol. 1982 Dec;78(3):728–739. doi: 10.1016/0014-4886(82)90087-5. [DOI] [PubMed] [Google Scholar]
  29. Dunbar G. C., Lishman W. A. Depression, recognition-memory and hedonic tone a signal detection analysis. Br J Psychiatry. 1984 Apr;144:376–382. doi: 10.1192/bjp.144.4.376. [DOI] [PubMed] [Google Scholar]
  30. Edwards E., Harkins K., Wright G., Henn F. Effects of bilateral adrenalectomy on the induction of learned helplessness behavior. Neuropsychopharmacology. 1990 Apr;3(2):109–114. [PubMed] [Google Scholar]
  31. Ettigi P. G., Brown G. M. Psychoneuroendocrinology of affective disorder: an overview. Am J Psychiatry. 1977 May;134(5):493–501. doi: 10.1176/ajp.134.5.493. [DOI] [PubMed] [Google Scholar]
  32. Feldman S., Weidenfeld J. Depletion of hypothalamic norepinephrine and serotonin enhances the dexamethasone negative feedback effect on adrenocortical secretion. Psychoneuroendocrinology. 1991;16(5):397–405. doi: 10.1016/0306-4530(91)90004-d. [DOI] [PubMed] [Google Scholar]
  33. Ffrench-Mullen J. M., Spence K. T. Neurosteroids block Ca2+ channel current in freshly isolated hippocampal CA1 neurons. Eur J Pharmacol. 1991 Sep 17;202(2):269–272. doi: 10.1016/0014-2999(91)90303-8. [DOI] [PubMed] [Google Scholar]
  34. Filipini D., Gijsbers K., Birmingham M. K., Dubrovsky B. Effects of adrenal steroids and their reduced metabolites on hippocampal long-term potentiation. J Steroid Biochem Mol Biol. 1991;40(1-3):87–92. doi: 10.1016/0960-0760(91)90171-z. [DOI] [PubMed] [Google Scholar]
  35. Foster T. C., McNaughton B. L. Long-term enhancement of CA1 synaptic transmission is due to increased quantal size, not quantal content. Hippocampus. 1991 Jan;1(1):79–91. doi: 10.1002/hipo.450010108. [DOI] [PubMed] [Google Scholar]
  36. Fuller R. W. Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology. 1981 Feb;32(2):118–127. doi: 10.1159/000123142. [DOI] [PubMed] [Google Scholar]
  37. Gibbons J. L. Editorial: Endocrinology and psychiatry. Psychol Med. 1974 Aug;4(3):240–243. doi: 10.1017/s0033291700042914. [DOI] [PubMed] [Google Scholar]
  38. Gifford S., Gunderson J. G. Cushing's disease as a psychosomatic disorder: a selective review of the clinical and experimental literature and a report of ten cases. Perspect Biol Med. 1970 Winter;13(2):169–221. doi: 10.1353/pbm.1970.0019. [DOI] [PubMed] [Google Scholar]
  39. Gold P. W., Chrousos G., Kellner C., Post R., Roy A., Augerinos P., Schulte H., Oldfield E., Loriaux D. L. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry. 1984 May;141(5):619–627. doi: 10.1176/ajp.141.5.619. [DOI] [PubMed] [Google Scholar]
  40. Gold P. W., Goodwin F. K., Chrousos G. P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1) N Engl J Med. 1988 Aug 11;319(6):348–353. doi: 10.1056/NEJM198808113190606. [DOI] [PubMed] [Google Scholar]
  41. Granner D. K. The role of glucocorticoid hormones as biological amplifiers. Monogr Endocrinol. 1979;12:593–611. doi: 10.1007/978-3-642-81265-1_33. [DOI] [PubMed] [Google Scholar]
  42. Harrison N. L., Majewska M. D., Harrington J. W., Barker J. L. Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex. J Pharmacol Exp Ther. 1987 Apr;241(1):346–353. [PubMed] [Google Scholar]
  43. Harrison N. L., Simmonds M. A. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 1984 Dec 10;323(2):287–292. doi: 10.1016/0006-8993(84)90299-3. [DOI] [PubMed] [Google Scholar]
  44. Hawkins D. R., Mendels J. Sleep disturbance in depressive syndromes. Am J Psychiatry. 1966 Dec;123(6):682–690. doi: 10.1176/ajp.123.6.682. [DOI] [PubMed] [Google Scholar]
  45. Heinz E. R., Martinez J., Haenggeli A. Reversibility of cerebral atrophy in anorexia nervosa and Cushing's syndrome. J Comput Assist Tomogr. 1977 Oct;1(4):415–418. doi: 10.1097/00004728-197710000-00006. [DOI] [PubMed] [Google Scholar]
  46. Hirschfeld R. M., Koslow S. H., Kupfer D. J. The clinical utility of the dexamethasone suppression test in psychiatry. Summary of a National Institute of Mental Health workshop. JAMA. 1983 Oct 28;250(16):2172–2174. [PubMed] [Google Scholar]
  47. Holsboer F., Gerken A., Stalla G. K., Müller O. A. Blunted aldosterone and ACTH release after human CRH administration in depressed patients. Am J Psychiatry. 1987 Feb;144(2):229–231. doi: 10.1176/ajp.144.2.229. [DOI] [PubMed] [Google Scholar]
  48. Holzbauer M., Birmingham M. K., De Nicola A. F., Oliver J. T. In vivo secretion of 3 alpha-hydroxy-5 alpha-pregnan-20-one, a potent anaesthetic steroid, by the adrenal gland of the rat. J Steroid Biochem. 1985 Jan;22(1):97–102. doi: 10.1016/0022-4731(85)90147-5. [DOI] [PubMed] [Google Scholar]
  49. Holzwarth M. A., Cunningham L. A., Kleitman N. The role of adrenal nerves in the regulation of adrenocortical functions. Ann N Y Acad Sci. 1987;512:449–464. doi: 10.1111/j.1749-6632.1987.tb24980.x. [DOI] [PubMed] [Google Scholar]
  50. Horvat A. Insulin binding sites on rat liver nuclear membranes: biochemical and immunofluorescent studies. J Cell Physiol. 1978 Oct;97(1):37–47. doi: 10.1002/jcp.1040970106. [DOI] [PubMed] [Google Scholar]
  51. Hua S. Y., Chen Y. Z. Membrane receptor-mediated electrophysiological effects of glucocorticoid on mammalian neurons. Endocrinology. 1989 Feb;124(2):687–691. doi: 10.1210/endo-124-2-687. [DOI] [PubMed] [Google Scholar]
  52. Irsy G., Koranyi L. Neuroendocrinological effects of ketoconazole in rats. Acta Endocrinol (Copenh) 1990 Mar;122(3):409–413. doi: 10.1530/acta.0.1220409. [DOI] [PubMed] [Google Scholar]
  53. Jeffcoate W. J., Silverstone J. T., Edwards C. R., Besser G. M. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol. Q J Med. 1979 Jul;48(191):465–472. [PubMed] [Google Scholar]
  54. Joëls M., de Kloet E. R. Control of neuronal excitability by corticosteroid hormones. Trends Neurosci. 1992 Jan;15(1):25–30. doi: 10.1016/0166-2236(92)90345-9. [DOI] [PubMed] [Google Scholar]
  55. Joëls M., de Kloet E. R. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science. 1989 Sep 29;245(4925):1502–1505. doi: 10.1126/science.2781292. [DOI] [PubMed] [Google Scholar]
  56. Ke F. C., Ramirez V. D. Binding of progesterone to nerve cell membranes of rat brain using progesterone conjugated to 125I-bovine serum albumin as a ligand. J Neurochem. 1990 Feb;54(2):467–472. doi: 10.1111/j.1471-4159.1990.tb01895.x. [DOI] [PubMed] [Google Scholar]
  57. Kelly W. F., Checkley S. A., Bender D. A., Mashiter K. Cushing's syndrome and depression--a prospective study of 26 patients. Br J Psychiatry. 1983 Jan;142:16–19. doi: 10.1192/bjp.142.1.16. [DOI] [PubMed] [Google Scholar]
  58. Kling M. A., Roy A., Doran A. R., Calabrese J. R., Rubinow D. R., Whitfield H. J., Jr, May C., Post R. M., Chrousos G. P., Gold P. W. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J Clin Endocrinol Metab. 1991 Feb;72(2):260–271. doi: 10.1210/jcem-72-2-260. [DOI] [PubMed] [Google Scholar]
  59. Kramlinger K. G., Peterson G. C., Watson P. K., Leonard L. L. Metyrapone for depression and delirium secondary to Cushing's syndrome. Psychosomatics. 1985 Jan;26(1):67–71. doi: 10.1016/S0033-3182(85)72906-4. [DOI] [PubMed] [Google Scholar]
  60. Kraulis I., Foldes G., Traikov H., Dubrovsky B., Birmingham Distribution, metabolism and biological activity of deoxycorticosterone in the central nervous system. Brain Res. 1975 Apr 25;88(1):1–14. doi: 10.1016/0006-8993(75)90942-7. [DOI] [PubMed] [Google Scholar]
  61. Krieger D. T. The central nervous system and Cushing's disease. Med Clin North Am. 1978 Mar;62(2):261–268. doi: 10.1016/s0025-7125(16)31803-x. [DOI] [PubMed] [Google Scholar]
  62. Kupfer D. J., Foster F. G., Detre T. P. Sleep continuity changes in depression. Dis Nerv Syst. 1973 Apr-May;34(4):192–195. [PubMed] [Google Scholar]
  63. Le Roith D., Shiloach J., Roth J., Lesniak M. A. Evolutionary origins of vertebrate hormones: substances similar to mammalian insulins are native to unicellular eukaryotes. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6184–6188. doi: 10.1073/pnas.77.10.6184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Linkowski P., Mendlewicz J., Kerkhofs M., Leclercq R., Golstein J., Brasseur M., Copinschi G., Van Cauter E. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab. 1987 Jul;65(1):141–152. doi: 10.1210/jcem-65-1-141. [DOI] [PubMed] [Google Scholar]
  65. Lishman W. A. Selective facotrs in memory. 2. Affective disorder. Psychol Med. 1972 Aug;2(3):248–253. doi: 10.1017/s0033291700042549. [DOI] [PubMed] [Google Scholar]
  66. Lishman W. A. The speed of recall of pleasant and unpleasant experiences. Psychol Med. 1974 May;4(2):212–218. doi: 10.1017/s0033291700042045. [DOI] [PubMed] [Google Scholar]
  67. Lloyd G. G., Lishman W. A. Effect of depression on the speed of recall of pleasant and unpleasant experiences. Psychol Med. 1975 May;5(2):173–180. doi: 10.1017/s0033291700056440. [DOI] [PubMed] [Google Scholar]
  68. Madison D. V., Malenka R. C., Nicoll R. A. Mechanisms underlying long-term potentiation of synaptic transmission. Annu Rev Neurosci. 1991;14:379–397. doi: 10.1146/annurev.ne.14.030191.002115. [DOI] [PubMed] [Google Scholar]
  69. Majewska M. D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol. 1992;38(4):379–395. doi: 10.1016/0301-0082(92)90025-a. [DOI] [PubMed] [Google Scholar]
  70. Malinow R., Tsien R. W. Presynaptic enhancement shown by whole-cell recordings of long-term potentiation in hippocampal slices. Nature. 1990 Jul 12;346(6280):177–180. doi: 10.1038/346177a0. [DOI] [PubMed] [Google Scholar]
  71. Martire M., Pistritto G., Preziosi P. Different regulation of serotonin receptors following adrenal hormone imbalance in the rat hippocampus and hypothalamus. J Neural Transm. 1989;78(2):109–120. doi: 10.1007/BF01252497. [DOI] [PubMed] [Google Scholar]
  72. Mason J. W. "Over-all" hormonal balance as a key to endocrine organization. Psychosom Med. 1968 Sep-Oct;30(5 Suppl):791–808. doi: 10.1097/00006842-196809000-00033. [DOI] [PubMed] [Google Scholar]
  73. Mason J. W. A re-evaluation of the concept of "non-specificity" in stress theory. J Psychiatr Res. 1971 Aug;8(3):323–333. doi: 10.1016/0022-3956(71)90028-8. [DOI] [PubMed] [Google Scholar]
  74. May C., Rapoport S. I., Tomai T. P., Chrousos G. P., Gold P. W. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease. Neurology. 1987 Mar;37(3):535–538. doi: 10.1212/wnl.37.3.535. [DOI] [PubMed] [Google Scholar]
  75. McEwen B. S., Angulo J., Cameron H., Chao H. M., Daniels D., Gannon M. N., Gould E., Mendelson S., Sakai R., Spencer R. Paradoxical effects of adrenal steroids on the brain: protection versus degeneration. Biol Psychiatry. 1992 Jan 15;31(2):177–199. doi: 10.1016/0006-3223(92)90204-d. [DOI] [PubMed] [Google Scholar]
  76. McEwen B. S., Biegon A., Davis P. G., Krey L. C., Luine V. N., McGinnis M. Y., Paden C. M., Parsons B., Rainbow T. C. Steroid hormones: humoral signals which alter brain cell properties and functions. Recent Prog Horm Res. 1982;38:41–92. doi: 10.1016/b978-0-12-571138-8.50007-x. [DOI] [PubMed] [Google Scholar]
  77. McEwen B. S., Davis P. G., Parsons B., Pfaff D. W. The brain as a target for steroid hormone action. Annu Rev Neurosci. 1979;2:65–112. doi: 10.1146/annurev.ne.02.030179.000433. [DOI] [PubMed] [Google Scholar]
  78. McEwen B. S., De Kloet E. R., Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev. 1986 Oct;66(4):1121–1188. doi: 10.1152/physrev.1986.66.4.1121. [DOI] [PubMed] [Google Scholar]
  79. McEwen B. S. Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem Pharmacol. 1987 Jun 1;36(11):1755–1763. doi: 10.1016/0006-2952(87)90234-6. [DOI] [PubMed] [Google Scholar]
  80. Milner B. Disorders of learning and memory after temporal lobe lesions in man. Clin Neurosurg. 1972;19:421–446. doi: 10.1093/neurosurgery/19.cn_suppl_1.421. [DOI] [PubMed] [Google Scholar]
  81. Mitchell D. M., Collins J. V. Do corticosteroids really alter mood? Postgrad Med J. 1984 Jul;60(705):467–470. doi: 10.1136/pgmj.60.705.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Mobley P. L., Sulser F. Adrenal corticoids regulate sensitivity of noradrenaline receptor-coupled adenylate cyclase in brain. Nature. 1980 Aug 7;286(5773):608–609. doi: 10.1038/286608a0. [DOI] [PubMed] [Google Scholar]
  83. Morris R. G., Anderson E., Lynch G. S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. 1986 Feb 27-Mar 5Nature. 319(6056):774–776. doi: 10.1038/319774a0. [DOI] [PubMed] [Google Scholar]
  84. Murphy B. E., Dhar V., Ghadirian A. M., Chouinard G., Keller R. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol. 1991 Apr;11(2):121–126. [PubMed] [Google Scholar]
  85. Murphy B. E. Steroids and depression. J Steroid Biochem Mol Biol. 1991 May;38(5):537–559. doi: 10.1016/0960-0760(91)90312-s. [DOI] [PubMed] [Google Scholar]
  86. Negro-Vilar A., Johnston C., Spinedi E., Valença M., Lopez F. Physiological role of peptides and amines on the regulation of ACTH secretion. Ann N Y Acad Sci. 1987;512:218–236. doi: 10.1111/j.1749-6632.1987.tb24963.x. [DOI] [PubMed] [Google Scholar]
  87. Nemeroff C. B. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J Clin Psychiatry. 1989 May;50 (Suppl):13–22. [PubMed] [Google Scholar]
  88. Nemeroff C. B. The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry. 1988 Mar;21(2):76–82. doi: 10.1055/s-2007-1014652. [DOI] [PubMed] [Google Scholar]
  89. O'Malley B. The steroid receptor superfamily: more excitement predicted for the future. Mol Endocrinol. 1990 Mar;4(3):363–369. doi: 10.1210/mend-4-3-363. [DOI] [PubMed] [Google Scholar]
  90. Okuno T., Ito M., Konishi Y., Yoshioka M., Nakano Y. Cerebral atrophy following ACTH therapy. J Comput Assist Tomogr. 1980 Feb;4(1):20–23. doi: 10.1097/00004728-198002000-00004. [DOI] [PubMed] [Google Scholar]
  91. Owens M. J., Edwards E., Nemeroff C. B. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain. Eur J Pharmacol. 1990 Nov 6;190(1-2):113–122. doi: 10.1016/0014-2999(90)94118-h. [DOI] [PubMed] [Google Scholar]
  92. Pfaff D. W. Features of a hormone-driven defined neural circuit for a mammalian behavior. Principles illustrated, neuroendocrine syllogisms, and multiplicative steroid effects. Ann N Y Acad Sci. 1989;563:131–147. doi: 10.1111/j.1749-6632.1989.tb42195.x. [DOI] [PubMed] [Google Scholar]
  93. Plotsky P. M. Regulation of hypophysiotropic factors mediating ACTH secretion. Ann N Y Acad Sci. 1987;512:205–217. doi: 10.1111/j.1749-6632.1987.tb24962.x. [DOI] [PubMed] [Google Scholar]
  94. Post R. M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992 Aug;149(8):999–1010. doi: 10.1176/ajp.149.8.999. [DOI] [PubMed] [Google Scholar]
  95. Puia G., Santi M. R., Vicini S., Pritchett D. B., Purdy R. H., Paul S. M., Seeburg P. H., Costa E. Neurosteroids act on recombinant human GABAA receptors. Neuron. 1990 May;4(5):759–765. doi: 10.1016/0896-6273(90)90202-q. [DOI] [PubMed] [Google Scholar]
  96. Racine R. J., Milgram N. W., Hafner S. Long-term potentiation phenomena in the rat limbic forebrain. Brain Res. 1983 Feb 7;260(2):217–231. doi: 10.1016/0006-8993(83)90676-5. [DOI] [PubMed] [Google Scholar]
  97. Racine R. Kindling: the first decade. Neurosurgery. 1978 Sep-Oct;3(2):234–252. doi: 10.1227/00006123-197809000-00018. [DOI] [PubMed] [Google Scholar]
  98. Ravaris C. L., Sateia M. J., Beroza K. W., Noordsy D. L., Brinck-Johnsen T. Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman. Arch Gen Psychiatry. 1988 Oct;45(10):966–967. doi: 10.1001/archpsyc.1988.01800340094019. [DOI] [PubMed] [Google Scholar]
  99. Reus V. I., Joseph M., Dallman M. Regulation of ACTH and cortisol in depression. Peptides. 1983 Sep-Oct;4(5):785–788. doi: 10.1016/0196-9781(83)90036-0. [DOI] [PubMed] [Google Scholar]
  100. Rey M., Carlier E., Soumireu-Mourat B. Effects of corticosterone on hippocampal slice electrophysiology in normal and adrenalectomized BALB/c mice. Neuroendocrinology. 1987 Nov;46(5):424–429. doi: 10.1159/000124856. [DOI] [PubMed] [Google Scholar]
  101. Roberts D. C., Bloom F. E. Adrenal steroid-induced changes in beta-adrenergic receptor binding in rat hippocampus. Eur J Pharmacol. 1981 Aug 27;74(1):37–41. doi: 10.1016/0014-2999(81)90320-4. [DOI] [PubMed] [Google Scholar]
  102. Roth J., LeRoith D., Shiloach J., Rosenzweig J. L., Lesniak M. A., Havrankova J. The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers: implications for mammalian biology. N Engl J Med. 1982 Mar 4;306(9):523–527. doi: 10.1056/NEJM198203043060907. [DOI] [PubMed] [Google Scholar]
  103. Rubinow D. R., Post R. M., Savard R., Gold P. W. Cortisol hypersecretion and cognitive impairment in depression. Arch Gen Psychiatry. 1984 Mar;41(3):279–283. doi: 10.1001/archpsyc.1984.01790140069008. [DOI] [PubMed] [Google Scholar]
  104. Sapolsky R. M., Plotsky P. M. Hypercortisolism and its possible neural bases. Biol Psychiatry. 1990 May 1;27(9):937–952. doi: 10.1016/0006-3223(90)90032-w. [DOI] [PubMed] [Google Scholar]
  105. Schatzberg A. F., Rothschild A. J. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Ann N Y Acad Sci. 1988;537:462–471. doi: 10.1111/j.1749-6632.1988.tb42128.x. [DOI] [PubMed] [Google Scholar]
  106. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci. 1990 Sep;13(9):359–362. doi: 10.1016/0166-2236(90)90016-4. [DOI] [PubMed] [Google Scholar]
  107. Shors T. J., Levine S., Thompson R. F. Effect of adrenalectomy and demedullation on the stress-induced impairment of long-term potentiation. Neuroendocrinology. 1990 Jan;51(1):70–75. doi: 10.1159/000125318. [DOI] [PubMed] [Google Scholar]
  108. Shors T. J., Seib T. B., Levine S., Thompson R. F. Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science. 1989 Apr 14;244(4901):224–226. doi: 10.1126/science.2704997. [DOI] [PubMed] [Google Scholar]
  109. Silberman E. K., Weingartner H., Targum S. D., Byrnes S. Cognitive functioning in biological subtypes of depression. Biol Psychiatry. 1985 Jun;20(6):654–661. doi: 10.1016/0006-3223(85)90100-3. [DOI] [PubMed] [Google Scholar]
  110. Sloviter R. S., Valiquette G., Abrams G. M., Ronk E. C., Sollas A. L., Paul L. A., Neubort S. Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science. 1989 Jan 27;243(4890):535–538. doi: 10.1126/science.2911756. [DOI] [PubMed] [Google Scholar]
  111. Spence K. T., Plata-Salaman C. R., ffrench-Mullen J. M. The neurosteroids pregnenolone and pregnenolone-sulfate but not progesterone, block Ca2+ currents in acutely isolated hippocampal CA1 neurons. Life Sci. 1991;49(26):PL235–PL239. doi: 10.1016/0024-3205(91)90649-v. [DOI] [PubMed] [Google Scholar]
  112. Starkman M. N., Schteingart D. E. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels. Arch Intern Med. 1981 Feb;141(2):215–219. [PubMed] [Google Scholar]
  113. Starkman M. N., Schteingart D. E., Schork M. A. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom Med. 1981 Feb;43(1):3–18. doi: 10.1097/00006842-198102000-00002. [DOI] [PubMed] [Google Scholar]
  114. Stokes P. E., Sikes C. R. The hypothalamic-pituitary-adrenocortical axis in major depression. Endocrinol Metab Clin North Am. 1988 Mar;17(1):1–19. [PubMed] [Google Scholar]
  115. Sulser F. Regulation and function of noradrenaline receptor systems in brain. Psychopharmacological aspects. Neuropharmacology. 1984 Feb;23(2B):255–261. doi: 10.1016/0028-3908(84)90067-4. [DOI] [PubMed] [Google Scholar]
  116. Swann A. C., Stokes P. E., Casper R., Secunda S. K., Bowden C. L., Berman N., Katz M. M., Robins E. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand. 1992 Apr;85(4):270–274. doi: 10.1111/j.1600-0447.1992.tb01468.x. [DOI] [PubMed] [Google Scholar]
  117. Talmi M., Carlier E., Rey M., Soumireu-Mourat B. Modulation of the in vitro electrophysiological effect of corticosterone by extracellular calcium in the hippocampus. Neuroendocrinology. 1992 Mar;55(3):257–263. doi: 10.1159/000126123. [DOI] [PubMed] [Google Scholar]
  118. Teyler T. J., Vardaris R. M., Lewis D., Rawitch A. B. Gonadal steroids: effects on excitability of hippocampal pyramidal cells. Science. 1980 Aug 29;209(4460):1017–1018. doi: 10.1126/science.7190730. [DOI] [PubMed] [Google Scholar]
  119. Towle A. C., Sze P. Y. Steroid binding to synaptic plasma membrane: differential binding of glucocorticoids and gonadal steroids. J Steroid Biochem. 1983 Feb;18(2):135–143. doi: 10.1016/0022-4731(83)90079-1. [DOI] [PubMed] [Google Scholar]
  120. Turner W. J. Dexamethasone suppression test: problems and promise. Biol Psychiatry. 1982 Jan;17(1):1–2. [PubMed] [Google Scholar]
  121. Weingartner H., Silberman E. Models of cognitive impairment: cognitive changes in depression. Psychopharmacol Bull. 1982 Apr;18(2):27–42. [PubMed] [Google Scholar]
  122. Wolkowitz O. M., Reus V. I., Weingartner H., Thompson K., Breier A., Doran A., Rubinow D., Pickar D. Cognitive effects of corticosteroids. Am J Psychiatry. 1990 Oct;147(10):1297–1303. doi: 10.1176/ajp.147.10.1297. [DOI] [PubMed] [Google Scholar]
  123. Wolkowitz O. M., Rubinow D., Doran A. R., Breier A., Berrettini W. H., Kling M. A., Pickar D. Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch Gen Psychiatry. 1990 Oct;47(10):963–968. doi: 10.1001/archpsyc.1990.01810220079010. [DOI] [PubMed] [Google Scholar]
  124. van Praag H. M. Depression. Lancet. 1982 Dec 4;2(8310):1259–1264. doi: 10.1016/s0140-6736(82)90115-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Medical Association

RESOURCES